Actively Recruiting
Study of a Non-Hormonal Gel for Treating Vulvovaginal Skin Conditions in Adult Women
Led by Stratpharma AG · Updated on 2026-02-20
2000
Participants Needed
14
Research Sites
26 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying vulvovaginal skin conditions such as vaginal atrophy, lichen sclerosus, lichen simplex chronicus, and lichen planus in adult women. The study aims to evaluate the short- and long-term safety and effectiveness of a new gel dressing device designed to support vulvovaginal mucosal health and promote recovery after vaginal rejuvenation. The investigational treatment being assessed is a non-hormonal, non-steroidal gel called 7-0940. This gel is intended to relieve symptoms like itchiness, dryness, burning, painful intercourse, and tenderness while improving skin conditions such as erythema and tissue thinning. The gel supports a moist healing environment to speed up tissue repair and is intended for long-term use without the side effects associated with hormonal or corticosteroid therapies. Participants will be observed over a 12-month period where researchers will measure changes in symptom scores, quality of life, and clinical signs using questionnaires and rating scales. Safety will be monitored by tracking adverse reactions and treatment adherence. The study involves using digital devices like smartphones or computers for communication and data collection. Total participation duration and detailed assessments are planned to understand the gels impact on vulvovaginal health over time.
CONDITIONS
Brief Title
VALOR: Vaginal Atrophy & Long-term Observation of Recovery
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here